SSA
GRCE

Schonfeld Strategic Advisors’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-604
Closed -$71K – 1572
2019
Q4 		$71K Buy
+604
New +$71K ﹤0.01% 1221